QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

 cyclerion-therapeutics-says-under-license-agreement-mit-eligible-for-up-to-44m-in-milestone-payments

-SEC Filing

 cyclerion-announces-license-agreement-with-mit-to-relaunch-advancing-phase-2ready-treatment-for-resistant-depression

– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT L...

 cyclerion-therapeutics-q2-eps-011-up-from-053-yoy-sales-9600k

Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.11) per share. This is a 79.25 percent increase over loss...

 cyclerion-therapeutics-has-received-a-notice-of-allowance-for-a-us-patent-titled-processes-and-intermediates-for-the-preparation-of-soluble-guanylate-cyclase-stimulators

https://patentcenter.uspto.gov/applications/18671182/ifw/docs

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION